Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balram Bhargava

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Journal of the American College of Cardiology|July 19, 2023
Complete Revascularization and Angina-Related Health Status in the ISCHEMIA TrialKreton Mavromatis, Philip G Jones, Ziad A Ali, et al.
The Lancet. Oncology|July 3, 2021
The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology researchPriya Ranganathan, Girish Chinnaswamy, Manju Sengar, et al.
The Lancet. Infectious Diseases|March 11, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trialRaches Ella, Siddharth Reddy, Harsh Jogdand, et al.
Circulation. Cardiovascular Quality and Outcomes|September 20, 2024
International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA TrialNobuhiro Ikemura, John A Spertus, Dan Nguyen, et al.
Lancet (London, England)|November 14, 2021
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trialRaches Ella, Siddarth Reddy, William Blackwelder, et al.
The New England Journal of Medicine|November 6, 2012
Strategies for multivessel revascularization in patients with diabetesMichael E Farkouh, Michael Domanski, Lynn A Sleeper, et al.
Journal of Human Hypertension|March 23, 2025
Population-based surveillance for hypertension awareness, treatment, and control in nine districts - India Hypertension Control Initiative, 2018-19Prabhdeep Kaur, Kamaraj Pattabi, Amirthammal Gunasekaran, et al.
Eclinicalmedicine|December 6, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in IndiaPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Plos One|December 21, 2023
Recurrence of pulmonary tuberculosis in India: Findings from the 2019-2021 nationwide community-based TB prevalence surveyPrathiksha Giridharan, Sriram Selvaraju, Raghuram Rao, et al.
The Indian Journal of Medical Research|September 11, 2015
Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction--MI3 TrialVelu Nair, Hemant Madan, Sunil Sofat, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Journal of the American College of Cardiology|July 19, 2023
Complete Revascularization and Angina-Related Health Status in the ISCHEMIA TrialKreton Mavromatis, Philip G Jones, Ziad A Ali, et al.
The Lancet. Oncology|July 3, 2021
The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology researchPriya Ranganathan, Girish Chinnaswamy, Manju Sengar, et al.
The Lancet. Infectious Diseases|March 11, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trialRaches Ella, Siddharth Reddy, Harsh Jogdand, et al.
Circulation. Cardiovascular Quality and Outcomes|September 20, 2024
International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA TrialNobuhiro Ikemura, John A Spertus, Dan Nguyen, et al.
Lancet (London, England)|November 14, 2021
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trialRaches Ella, Siddarth Reddy, William Blackwelder, et al.
The New England Journal of Medicine|November 6, 2012
Strategies for multivessel revascularization in patients with diabetesMichael E Farkouh, Michael Domanski, Lynn A Sleeper, et al.
Journal of Human Hypertension|March 23, 2025
Population-based surveillance for hypertension awareness, treatment, and control in nine districts - India Hypertension Control Initiative, 2018-19Prabhdeep Kaur, Kamaraj Pattabi, Amirthammal Gunasekaran, et al.
Eclinicalmedicine|December 6, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in IndiaPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Plos One|December 21, 2023
Recurrence of pulmonary tuberculosis in India: Findings from the 2019-2021 nationwide community-based TB prevalence surveyPrathiksha Giridharan, Sriram Selvaraju, Raghuram Rao, et al.
The Indian Journal of Medical Research|September 11, 2015
Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction--MI3 TrialVelu Nair, Hemant Madan, Sunil Sofat, et al.
Pageof 20